Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-24-043870
Filing Date
2024-10-28
Accepted
2024-10-28 08:24:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 lenztherapeutics424b3sticka.htm 424B3 33014
2 lenzlogo.jpg GRAPHIC 133057
  Complete submission text file 0001628280-24-043870.txt   191403
Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-282036 | Film No.: 241398483
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)